Royalindo Investa Wijaya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Royalindo Investa Wijaya Tbk. trades at Rp176 (market cap 788.61B, 21.91M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is the larger of the two by market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (21.91M versus 843K). Which is the better fit depends on your goals.
| INDO | LABS | |
|---|---|---|
Market Cap | 788.61B | 635.95B |
Volume | 21.91M | 843K |
Lot | 219.11K | 8.43K |
Turnover | 3.83B | 137.6M |
Average Price | 174.83 | 163.22 |
Value | 3.83B | 137.6M |
Indicative Equilibrium Price | 176 | 165 |
Indicative Equilibrium Volume | 114 | 246 |
Trailing returns across standard periods
Latest headlines on both assets
PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.
Read more on INDO →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →